ERIC Supports Senate Legislation to Hold Hospitals Accountable to Price Transparency Regulations

WASHINGTON, DC, March 24, 2023 – The ERISA Industry Committee (ERIC) issued a letter of support today for the Hospital Transparency Compliance Enforcement Act (S. 468), legislation introduced by Senator John Kennedy (R-LA) that would impose higher fines for hospitals that do not make publicly available the cost of contracted health care services with insurers – holding hospitals accountable to the 2021 Price Transparency Regulations.

The “Pharmacy Benefit Manager Transparency Act” Does Too Little to Bring Transparency and Accountability to the Prescription Drug Market

WASHINGTON, DC, March 22, 2023 – In a letter sent yesterday to the U.S. Senate Committee on Commerce, Science, and Transportation, The ERISA Industry Committee (ERIC) urged the members to vote no on the Pharmacy Benefit Manager Transparency Act (PBMTA, S. 127), legislation that fails to include employer-focused, comprehensive solutions that would bring clarity and responsibility to the prescription drug supply chain.